Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy
We conducted untargeted metabolomics analysis of plasma samples from a cross-sectional case–control study with 30 healthy controls, 30 patients with diabetes mellitus and normal renal function (DM-N), and 30 early diabetic nephropathy (DKD) patients using liquid chromatography-mass spectrometry (LC-...
Main Authors: | Yan Ming Tan, Yan Gao, Guoshou Teo, Hiromi W.L. Koh, E Shyong Tai, Chin Meng Khoo, Kwok Pui Choi, Lei Zhou, Hyungwon Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/4/228 |
Similar Items
-
Changes in the Risk of Stroke in Dialysis Patients: A Retrospective Analysis over the Last 40 Years
by: Toshiya Aono, et al.
Published: (2021-05-01) -
The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
by: Youssef Bennis, et al.
Published: (2019-05-01) -
Comprehensive Lipidome Profiling of the Kidney in Early-Stage Diabetic Nephropathy
by: Biyu Hou, et al.
Published: (2020-06-01) -
Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins
by: Helga Stopper, et al.
Published: (2010-10-01) -
Adiponectin for the treatment of diabetic nephropathy
by: Jun Young Lee, et al.
Published: (2019-05-01)